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Monday, March 2, 2009 273atransmembrane flux/exchange of the metabolites. These transporters may pos-
sess novel and as yet unidentified characteristics that are in proportion to their
critical role in cell metabolism. Evidence has been presented that they function
as homodimers (1) even though each subunit appears to posses its own metab-
olite transport path (2). We have expressed some of these transporter subunits as
bacterial inclusion bodies. Homodimers but not complexes with more than two
subunits can be formed and such dimers are able to catalyze metabolite transport
or exchange when incorporated into liposomes. We find now that dimers can
also be formed between subunits of different transporters (carriers), i.e. between
phosphate and oxaloacetate or between phosphate and dicarboxylate. These ex-
periments suggest that the subunit interface of different transporters must be
very much alike. Heterodimers have never been purified from or identified in
mitochondria. The homodimers are formed during insertion into the mitochon-
drial membrane (3). These membrane insertion steps are very important since
a heterodimer of different transporter subunits can lead to an inappropriate ex-
change of metabolites that can be deleterious to oxidative phosphorylation and
to the link between metabolic reactions of the matrix and the cytosol.
(1) J. Biol. Chem. (1998) 273 14269.
(2) Nature (2003) 426 39.
(3) Science (2003) 299 1747.
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Zinc transporter ZnT5 was determined to protect from intracellular zinc over-
load. We asked whether ZnT5 participates in intracellular signaling and regu-
lation of cell function. Using adult rat cardiomyocytes and cultured atrial cells,
HL-1, we investigated interaction of ZnT proteins with protein kinase C
(PKC). ZnT5 was found to co-precipitate with PKC isoforms d and e. Complex
formation was zinc-dependent: zinc-depletion with the specific chelator TPEN
promoted interaction. PKC activators increased ZnT5 association with PKC e
and dissociated PKC d from the complex. To determine functional significance
we assessed translocation of PKC isoforms in HL-1 cells. The cells were trans-
fected with ZnT5cDNA or the mutated dominant negative (DN) form. When
ZnT5 expression was modified, localization of both PKC isoforms was altered,
particularly pronounced with DN ZnT expression that resulted in disappear-
ance of PKCd from the Golgi complex. ZnT5 was found to localize in the Golgi
in proliferating cultured HL-1 cells but not in adult cardiomyocytes where sar-
comeric pattern was observed. Overexpression of ZnT5 enhanced proliferation
of HL-1 cells. High demand for ZnT5 in the cells with high rate of proliferation
was confirmed in the developing embryos and embryonic bodies. ZnT5 was
prevalent in the areas of highly proliferating cells belonging to inner cell
mass and not the differentiated ones surrounding basement membrane stained
for laminin. Biochemical experiments confirmed that highly proliferating cells
in embryonic bodies at stage D2 have higher expression of ZnT5 but not a-actin
as compared to D7 stage of development. The expression of a-fetal protein (a-
FP) at day 7 indicates differentiation. The data suggest that in addition of con-
trolling zinc homeostasis, ZnT5 zinc transporter plays an important role in sig-
naling. Both functions are likely required for cell survival, proliferation and
therefore cardioprotection and embryonic development.
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Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophos-
phate (cGMP) are second messengers which regulate many biological pro-
cesses. They can be eliminated by active efflux transporters, namely the
multidrug resistance proteins MRP4 and MRP5. To delineate the role of
MRP4/5, we studied arterial smooth muscle cells in which the role of cyclic nu-
cleotide levels on proliferation has been well-established.
Methods: Human SMCs were isolated from the coronary artery media from
patients. Small interfering RNAs (siRNA) specific for MRP4 mRNA were
designed and validated. Adenovirus encoding MRP4 short hairpin RNA
(Ad-shMRP4) were used for in vivo studies.
Results: MRP4 was over-expressed in serum-induced proliferating SMC as
well as in atherosclerotic plaques in human coronary arteries and in neo-intimaof injured rat carotid arteries. Inhibition of MRP4 by siRNA blocked VSMC
proliferation in vitro. In balloon-injured rat carotid arteries, intima/media ratios
were significantly lower in Ad-shMRP4-infected arteries than in Ad-shLucifer-
ase-infected arteries (0.65 5 0.1 vs 1.05 5 0.2; p<0.03). In vitro, MRP4 in-
hibition significantly increased intracellular cAMP and cGMP levels. A PKA
inhibitor (PKI) but not the PKG inhibitor (KT5823) completely reversed the
anti-proliferative effect of MRP4 inhibition. The level of pCREB increased
by 3295 18.8% (p¼0.003) on MRP4 inhibition.Conclusion: We provide first
evidences that MRP4 acts as an independent endogenous regulator of cyclic
nucleotides intra-cellular levels in vascular smooth muscle cells
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Intracellular calcium (Ca) dysregulation associated with cardiac disease (e.g.
heart failure) has been linked to mechanisms of ventricular arrhythmias.
Such arrhythmias can arise at the sub-cellular level from delayed afterdepola-
rizations that are due to spontaneous calcium release from the sarcoplasmic re-
ticulum. The mechanisms that govern an aggregate of sub-cellular spontaneous
calcium release events at the tissue level (i.e. an SCR) are not well understood.
We hypothesize that in tissue, an SCR can be significantly influenced by rya-
nodine receptor (RyR) function. Methods: High resolution optical mapping
of Ca (Indo-1AM) from the anterior surface of the Langendorff perfused guinea
pig heart (n¼4) was performed in hearts under high Ca conditions
([Ca2þ]e¼5.5mM), with and without caffeine (CAFF, 1mM) to enhance RyR
open probability. Endocardial cryoablation was performed to eliminate Pur-
kinje fibers and cytochalasin-D (7mM) was administered to remove motion ar-
tifact. Fifteen seconds of rapid pacing (400-160 ms cycle length) followed by
a pause was used to induce SCR activity. Results: In all preparations, synchro-
nized SCR activity was observed across the entire anterior surface of the heart
with and without CAFF. SCR activity increased in magnitude and occurred ear-
lier with decreasing pacing cycle length. With CAFF, the amplitude of SCR ac-
tivity increased (þ10.9%, p < 0.05) and occurred earlier (þ15.6%, p < 0.05).
CAFF also decreased the spatial heterogeneity of SCR onset across the map-
ping field (-37.4%, p < 0.05), suggesting that increased RyR open probability
enhances the synchronization of SCR activity. Conclusions: These results
demonstrate that sub-cellular spontaneous calcium release events (an SCR in
tissue) occur over a broad region of the intact heart and are enhanced when
RyR open probability is increased. SCR activity may be an important
mechanism of arrhythmogenesis in heart disease associated with calcium
dysregulation.
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Arrhythmia arises from the breakdown of synchronous ion handling. Abnormal
intracellular Ca2þ cycling has emerged as a primary driver for subsequent ar-
rhythmogenic perturbations in sarcolemmal Naþ and Kþ fluxes. Consequently,
therapeutic manipulation of intracellular Ca2þ handling represents a key target
for new anti-arrhythmic strategies. In order to better understand the potential
modes of modulating Ca2þ cycling that may underpin feasible anti-arrhythmic
approaches, we focussed on dissecting the relationships between the spatiotem-
poral aspects of Ca2þ release and intercellular (dys)synchrony. Ca2þ-dependent
fluo-4 signals recorded in spontaneously oscillating, electrically-coupled cardi-
omyocytes were decoded using the Synchronicity-Amplitude-Length and
Variability of Oscillation (SALVO) program that describe ‘contractile’ and
‘non-contractile’ aspects of Ca2þ handling. In 40 separate experiments (n>
500 cells), intercellular synchronisation of Ca2þ release and sequestration
was relatively constant (42.75 2.5%) over wide ranges of Ca2þ transients pro-
files (transient areas of 7 - 117 units) and oscillatory frequencies (0.026 -
2.17Hz). Surprisingly, the relative areas of Ca2þ transients (reflecting the am-
plitude and kinetics of Ca2þ release and sequestration) were not linked to the
oscillatory frequency. Although high levels of intercellular synchrony persisted
despite a remarkable plasticity in both the frequencies and shapes of Ca2þ tran-
sients, we found that the transients became more uniformly ordered at
